Land: Bandaríkin
Tungumál: enska
Heimild: NLM (National Library of Medicine)
AMOXICILLIN (UNII: 804826J2HU) (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)
American Antibiotics,Inc
AMOXICILLIN
AMOXICILLIN 250 mg
ORAL
PRESCRIPTION DRUG
Amoxicillin is indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) strains of the designated microorganisms in the conditions listed below: Infections of the ear, nose, and throat - due to Streptococcus spp. (α- and β- hemolytic strains only), S. pneumoniae , Staphylococcus spp., or H. influenzae . Infections of the genitourinary tract - due to E. coli, P. mirabilis, or E. faecalis . Infections of the skin and skin structure - due to Streptococcus spp. (α- and β-hemolytic strains only), Staphylococcus spp., or E. coli . Infections of the lower respiratory tract - due to Streptococcus spp. (α- and β-hemolytic strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae . Gonorrhea, acute uncomplicated (ano-genital and urethral infections) - due to N. gonorrhoeae (males and females). H. pylori eradication to reduce the risk of duodenal ulcer recurrence. Triple Therapy Amoxicillin/Clarithromycin/Lansoprazole Amoxicillin, in combination with clarithromycin
Each capsule contains amoxicillin trihydrate equivalent to 250 mg or 500 mg amoxicillin. 250 mg Capsule Caramel opaque cap and buff opaque body of the 250 mg capsule are imprinted with AA and 820 respectively. NDC 15749-820-04 bottles of 100 NDC 15749-820-10 bottles of 500 NDC 15749-820-11 bottles of 1000 500 mg Capsule Buff opaque cap and buff opaque body of the 500 mg capsule are imprinted with AA and 825 respectively. NDC 15749-825-02 bottles of 50 NDC 15749-825-04 bottles of 100 NDC 15749-825-10 bottles of 500 Store capsules at 20 o C to 25 o C (68 o F to 77 o F) [See USP Controlled Room Temperature]
Abbreviated New Drug Application
AMOXICILLIN - AMOXICILLIN CAPSULE AMERICAN ANTIBIOTICS,INC ---------- AMOXICILLIN CAPSULES, USP 250 MG AND 500 MG Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs, amoxicillin is to be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Formulations of amoxicillin capsules, USP contain amoxicillin, a semi-synthetic antibiotic, an analog of ampicillin, with a broad spectrum of bactericidal activity against many gram-positive and gram-negative microorganisms. Chemically, it is (2_S_, 5_R_, 6_R_)-6-[(_R_)-(-)-2-amino-2-(_p_-hydroxyphenyl) acetamido] -3,3- dimethyl-7-oxo-4-thia-1-azabicyclo [3.2.0] heptane-2-carboxylic acid trihydrate. It may be represented structurally as: The amoxicillin molecular formula is C H N O S·3H O, and the molecular weight is 419.45. Capsules of Amoxicillin are intended for oral administration. Each capsule contains amoxicillin trihydrate equivalent to 250 mg or 500 mg amoxicillin. Caramel opaque cap and buff opaque body of the 250 mg capsule are imprinted with AA and 820 respectively. Each 250 mg capsule contains the following inactive ingredients: magnesium stearate, sodium lauryl sulfate, D&C Yellow No. 10, FD&C Yellow No. 6, FD&C Blue No. 1, FD&C Red No. 3, titanium dioxide and gelatin. Buff opaque cap and buff opaque body of the 500 mg capsule are imprinted with AA and 825 respectively. Each 500 mg capsule contains the following inactive ingredients: magnesium stearate, sodium lauryl sulfate, D&C Yellow No. 10, FD&C Yellow No. 6, titanium dioxide and gelatin. CLINICAL PHARMACOLOGY Amoxicillin is stable in the presence of gastric acid and is rapidly absorbed after oral administration. The effect of food on the absorption of amoxicillin from the tablets and suspension of amoxicillin has been partially investigated. The 400 mg and 875 mg formulations have been studied only when administered at the start of a light meal. However, food ef Lestu allt skjalið